Peter Deak
23 posts
@Deak_Lab
Immunoengineer and Assistant Professor at Drexel University Chemical and Bioengineering Department We work on poking Dendritic Cells with chemistry!
Lila Sciences may raise about $2 billion at an $8.5 billion valuation. That number looks incredible if you treat Lila as a normal AI biotech. It makes a little more sense (maybe!) if you treat it as a bet on a new R&D operating system. Lila’s pitch is AI Science Factories: AI systems connected to automated labs that generate hypotheses, design experiments, run them, learn from the results, and repeat. In other words: model, robot lab, experiment, data, repeat. The whole shebang. Or “scientific superintelligence” and “operating system for science," as Lila calls it. (3/7)
There will be lots of narratives about this proposal to cap grants per NIH investigator given the fraught political climate but I’m glad the NIH is continuing to grapple with how best to responsibly distribute the public dollars still in its charge As with all requests for information on important policy proposals, I suspect there will be shockingly few respondents. And the responses that are sent will likely be dominated by backlash from those quite practiced and efficient at lobbying for their individual interests, even if they represent a vocal and powerful minority relative to a broader ecosystem that this would impact. If this affects you (though I’d argue distribution of resources by the largest public funder of health research in the world affects all of us), I’d do my homework and weigh in. grants.nih.gov/grants/guide/n…
